Syschem (India) Ltd

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 February 2026, providing investors with the most recent insights into its performance and outlook.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Syschem (India) Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, has experienced a significant shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid sector-wide valuation trends and company-specific financial metrics, prompting investors to reassess the stock’s price attractiveness relative to its historical and peer benchmarks.

Syschem (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 3 February 2026. This adjustment follows a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and market-beating returns, evolving technical indicators and a shift to fair valuation have tempered the outlook, prompting a more cautious stance.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a deterioration in the stock’s medium to long-term momentum.

Syschem (India) Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, driven primarily by its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change reflects evolving market perceptions and invites a closer examination of the company’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector.

Syschem (India) Ltd., a micro-cap pharmaceutical API manufacturer, delivered a remarkable turnaround in Q3 FY26 with net profit surging to ₹4.17 crores—a sequential jump of 119.47% from Q2's ₹1.90 crores and an impressive 734% year-on-year leap from ₹0.50 crores in Q3 FY25. The company's stock responded enthusiastically, rallying 7.00% on February 02, 2026 to close at ₹51.99, though the shares remain 16.15% below their 52-week high of ₹62.00.

Syschem (India) Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across key parameters including quality, valuation, financial trends, and technical indicators. This upgrade, effective from 1 February 2026, follows a period of robust financial performance and evolving market sentiment that positions the company favourably within the Pharmaceuticals & Biotechnology sector.

Syschem (India) Ltd’s investment rating has been downgraded from Buy to Hold as of 27 Jan 2026, reflecting a nuanced reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. Despite impressive recent financial performance, the stock’s technical outlook and valuation premium have prompted a more cautious stance among analysts.

Syschem (India) Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Syschem (India) Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 January 2026, providing investors with the latest insights into its performance and outlook.

Syschem (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 30 Dec 2025. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance, the stock’s technical indicators and valuation metrics have prompted a more cautious stance from analysts.

Syschem (India) Ltd is rated Buy by MarketsMOJO, with this rating last updated on 09 Dec 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 24 December 2025, providing investors with the latest insights into its performance and outlook.

Syschem (India), a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced view of its recent financial and technical performance. This adjustment comes amid a backdrop of strong operating profit growth contrasted with valuation concerns and moderate management efficiency.